Literature DB >> 19629768

Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy.

Laura Richert1, Andrea Trombetti, François R Herrmann, Frédéric Triponez, Christian Meier, John H Robert, René Rizzoli.   

Abstract

OBJECTIVE: Primary hyperparathyroidism (PHPT) is a frequently encountered endocrine disease in the elderly, but little is known about ist epidemiology in the aging European population. This study investigates the age- and sex-dependence of PHPT and the incidence of parathyroidectomy (PTX) in Switzerland, a country with a particularly high life expectancy.
DESIGN: A population-based study was performed using data from the Swiss Federal Statistical Office covering years 2000 to 2004. Anonymised hospital discharge codes for PHPT and PTX were analysed, and the hospitalisation rate for PHPT and incidence of PTX were calculated.
RESULTS: The mean annual hospitalisation rate of patients with PHPT was 8.3/100,000 inhabitants. The rate was approximately three times higher in women than in men, with the highest estimate found in women > or = 80 years (63.7/ 100,000). The population-adjusted annual incidence of PTX was 3.8/100,000 inhabitants. PTX incidence was higher in individuals > or = 50 years than in younger persons (8.7/100,000 vs 1.3/100,000), with a peak in patients aged 70-74 years.
CONCLUSIONS: In a European population with high life expectancy, the hospitalisation rate of PHPT is higher in women and increases continuously with age. Incidence of PTX is highest in patients aged 70-74 years. These findings underscore the need for further research on the impact of population aging on the treatment patterns of PHPT.

Entities:  

Mesh:

Year:  2009        PMID: 19629768     DOI: smw-12635

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  14 in total

1.  Sex and age modify biochemical and skeletal manifestations of chronic hyperparathyroidism by altering target organ responses to Ca2+ and parathyroid hormone in mice.

Authors:  Zhiqiang Cheng; Nathan Liang; Tsui-Hua Chen; Alfred Li; Christian Santa Maria; Michael You; Hanson Ho; Fuqing Song; Daniel Bikle; Chialing Tu; Dolores Shoback; Wenhan Chang
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

2.  Incidence and prevalence of primary hyperparathyroidism in a racially mixed population.

Authors:  Michael W Yeh; Philip H G Ituarte; Hui Cynthia Zhou; Stacie Nishimoto; In-Lu Amy Liu; Avital Harari; Philip I Haigh; Annette L Adams
Journal:  J Clin Endocrinol Metab       Date:  2013-02-15       Impact factor: 5.958

3.  Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms.

Authors:  A Trombetti; E R Christ; C Henzen; G Gold; M Brändle; F R Herrmann; C Torriani; F Triponez; M Kraenzlin; R Rizzoli; C Meier
Journal:  J Endocrinol Invest       Date:  2016-01-07       Impact factor: 4.256

4.  Successful minimally invasive surgery for primary hyperparathyroidism: influence of preoperative imaging and intraoperative parathyroid hormone levels.

Authors:  Gaëtan-Romain Joliat; Nicolas Demartines; Luc Portmann; Ariane Boubaker; Maurice Matter
Journal:  Langenbecks Arch Surg       Date:  2015-11-21       Impact factor: 3.445

5.  Hospital care for primary hyperparathyroidism in Italy: a 6-year register-based study.

Authors:  Cristiana Cipriani; Vincenzo Carnevale; Federica Biamonte; Sara Piemonte; Jessica Pepe; Luciano Nieddu; John P Bilezikian; Salvatore Minisola
Journal:  Eur J Endocrinol       Date:  2014-07-11       Impact factor: 6.664

Review 6.  Parathyroid Disease in Pregnancy and Lactation: A Narrative Review of the Literature.

Authors:  Elena Tsourdi; Athanasios D Anastasilakis
Journal:  Biomedicines       Date:  2021-04-26

7.  Primary hyperparathyroidism in older people: surgical treatment with minimally invasive approaches and outcome.

Authors:  Chiara Dobrinja; Marta Silvestri; Nicolò de Manzini
Journal:  Int J Endocrinol       Date:  2012-06-12       Impact factor: 3.257

Review 8.  Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.

Authors:  A A Khan; D A Hanley; R Rizzoli; J Bollerslev; J E M Young; L Rejnmark; R Thakker; P D'Amour; T Paul; S Van Uum; M Zakaria Shrayyef; D Goltzman; S Kaiser; N E Cusano; R Bouillon; L Mosekilde; A W Kung; S D Rao; S K Bhadada; B L Clarke; J Liu; Q Duh; E Michael Lewiecki; F Bandeira; R Eastell; C Marcocci; S J Silverberg; R Udelsman; K Shawn Davison; J T Potts; M L Brandi; J P Bilezikian
Journal:  Osteoporos Int       Date:  2016-09-09       Impact factor: 4.507

9.  The prevalence of primary hyperparathyroidism in Korea: a population-based analysis from patient medical records.

Authors:  Jong-Kyu Kim; Young Jun Chai; Jung Kee Chung; Ki-Tae Hwang; Seung Chul Heo; Su-Jin Kim; June Young Choi; Ka Hee Yi; Sang Wan Kim; Sung Yong Cho; Kyu Eun Lee
Journal:  Ann Surg Treat Res       Date:  2018-04-30       Impact factor: 1.859

10.  Undiagnosed Primary Hyperparathyroidism and Recurrent Miscarriage: The First Prospective Pilot Study.

Authors:  Aimee DiMarco; Ioannis Christakis; Vasilis Constantinides; Lesley Regan; F Fausto Palazzo
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.